At the halfway point of the resumed fifth session of the Intergovernmental Negotiating Committee (INC-5.2) in Geneva to deve ...

Nepali mixed martial artist Ravindra Dhat has captured national and international attention after he won the bantamweight ...

According to estimates by the Federation of Indian Export Organisations, about 55 per cent of exports to the US will be ...

US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...

The Arizona congressional delegation should stand up for our bioscience sector and oppose any policy like Most Favored Nation ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.

Trump's Bold Steps to Lower Prescription Drug Prices Ignite Hope** In a powerful move to alleviate the financial burden on American families, President Donald Trump has signed a ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create pressure on the ...